Wites & Kapitan

Call For Free Consultation

WITES & KAPETAN ANNOUNCES INVESTIGATION OF CHEFS’ WAREHOUSE, INC. (CHEF)

On January 27, 2014 after the market closed, Chefs’ Warehouse, Inc. (“Chefs’ Warehouse” or the “Company”) (Nasdaq: CHEF) issued a press release announcing that the Company expects fiscal 2013 financial results to be below its previously announced guidance. Additionally, the Company disclosed that its fourth quarter results were negatively impacted by “a significant charge related to an accounting issue” involving its Michaels’ Finer Meats subsidiary.  The press release also states “[i]n regard to the accounting issue, the Company has determined that an employee involved  in the financial reporting process at its Michaels’ Finer Meats subsidiary acquired in August 2012, deliberately made unsupported...

Read More

AHMC HEALTHCARE INC. PATIENT DATA BREACH IMPACTS APROXIMATELY 729,000 PATIENTS

Wites & Kapetan, P.A. is investigating potential claims involving the theft of two laptops on October 12, 2013 from a secured administration office of AHMC Healthcare Inc. (“AHMC”).  According to AHMC, the laptops contained protected health information for approximately 729,000 Medicare patients treated at the following AHMC hospitals: (1) Garfield Medical Center, (2) Monterey Park Hospital, (3) Greater El Monte Community Hospital, (4) Whittier Hospital Medical Center, (5) San Gabriel Valley Medical Center, and (6) Anaheim Regional Medical Center.  The protected health information contained in the laptops includes patient names, Medicare/insurance identification numbers, diagnosis/procedure codes, and insurance/patient payments.  AHMC has stated that...

Read More

INVESTIGATION OF AEGERION PHARMACEUTICALS, INC.

A class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who purchased Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR) securities between March 15, 2012 and January 9, 2014. The complaint alleges that the defendants made false and/or misleading statements and/or failed to disclose that Aegerion marketed its drugs in violation of the Federal Food Drug and Cosmetic Act. It is alleged that as a result of these violations, the Company exposed itself to heightened regulatory scrutiny by the FDA and other governmental bodies, and that Aegerion’s statements regarding the Company’s business,...

Read More

What does an insurance claims adjuster do?

What does an insurance claims adjuster do? An insurance claims adjuster conducts investigations into claims covered by an insurance policy. These can be any type of claim, from personal injury to property damage. In property damage claims, the main role of the insurance adjuster is to carry out a detailed investigation into the claim by: – Inspecting the damage – Reviewing any police reports – Speaking to any witnesses – Talking to the property owners Once the investigation is complete, the adjuster will then be in a position to determine the amount of the insurance company’s potential liability to its...

Read More

What should I do if my insurance claim adjustment is too low?

WHAT SHOULD I DO IF MY INSURANCE COMPANY DOES NOT PAY THE FULL VALUE OF MY CLAIM, OR DENIES MY CLAIM AND REFUSES TO COMPENSATE ME? My insurance company refuses to pay the full value of my claim. What do I do? You do not have to accept the valuation assigned to your claim by your insurance company. You have rights under your insurance company to receive all of the benefits for which you have paid insurance premiums. If the insurance company and its insurance claims adjuster have under valued your claim, you should immediately contact a lawyer to review...

Read More

INVESTOR ALERT: WITES & KAPETAN ANNOUNCES INVESTIGATION OF INVESTOR LOSSES IN NET 1 UEPS TECHNOLOGIES, INC., AND CLASS ACTION LAWSUIT

On December 4, 2012, Net 1 UEPS Technologies, Inc. (“Net 1” or the “Company”) (NASDAQ: UEPS) disclosed that it was under investigation by the U.S. Department of Justice, Criminal Division and the Division of the Enforcement of the Securities and Exchange Commission to determine whether the Company has “violated provisions of the Foreign Corrupt Practices Act and other U.S. federal criminal laws by engaging in a scheme to make corrupt payments to officials of the Government of South Africa in connection with securing a contract with [the] South African Social Security Agency (“SASSA”) to provide social welfare and benefits payments.”   Following...

Read More